1.

La reconnaissance par le juge belge d’une immunité à un Etat ou à une organisation internationale viole-t-elle le droit d’accès à un tribunal?

2.

La reconnaissance par le juge belge d’une immunité à un Etat ou à une organisation internationale viole-t-elle le droit d’accès à un tribunal?

1.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

2.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

3.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

4.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

5.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

6.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

7.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

8.

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care...

1.

The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs.

2.

The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs.

1.

Data from: Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

2.

Data from: Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

3.

Data from: Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

4.

Data from: Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

5.

Data from: Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium

1.

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy

2.

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy

1.

Immunogenicity of One-Dose Quadrivalent Human Papillomavirus Vaccine in Girls

2.

Immunogenicity of One-Dose Quadrivalent Human Papillomavirus Vaccine in Girls

1.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

2.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

3.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

4.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

5.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

6.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

7.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

8.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

9.

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.

1.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventil...

2.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventil...

3.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventil...

4.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventil...

5.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventil...

1.

Equity in prevention and health care

2.

Equity in prevention and health care

3.

Equity in prevention and health care

4.

Equity in prevention and health care

5.

Equity in prevention and health care

6.

Equity in prevention and health care

7.

Equity in prevention and health care

8.

Equity in prevention and health care

1.

Domestic workers in diplomats' households: rights violations and access to justice in the context of diplomatic immunity

2.

Domestic workers in diplomats' households: rights violations and access to justice in the context of diplomatic immunity

3.

Domestic workers in diplomats' households: rights violations and access to justice in the context of diplomatic immunity

4.

Domestic workers in diplomats' households: rights violations and access to justice in the context of diplomatic immunity

5.

Domestic workers in diplomats' households: rights violations and access to justice in the context of diplomatic immunity